INVESTIGATION OF THE ASSOCIATION BETWEEN SERUM C-REACTIVE PROTEIN DYNAMICS AND THE DEVELOPMENT OF SEPTIC SHOCK AND THE REQUIREMENT FOR INVASIVE MECHANICAL VENTILATION IN HOSPITALIZED PATIENTS WITH COMMUNITY-ACQUIRED PNEUMONIA

Thị Mỹ Huyền Nguyễn1, Vĩnh Niên Lâm1, Thành Vinh Trần2,
1 Đại học Y Dược TPHCM
2 Bệnh viện Chợ Rẫy

Main Article Content

Abstract

Objective: To investigate the prognostic significance of the relative change in serum C-reactive protein (CRP) between day 1 and day 3 for predicting the development of septic shock and the requirement for invasive mechanical ventilation (IMV) in hospitalized patients with community-acquired pneumonia (CAP), and to determine the optimal cut off values of ΔCRP % for these adverse outcomes.


Materials and methods: A prospective observational cohort study was conducted on 128 adult inpatients (≥18 years) with CAP admitted to Cho Ray Hospital from October 2024 to March 2025. Serum CRP concentrations were quantified on days 1 and 3 using a latex-enhanced immunoturbidimetric assay.


Results: Among 128 patients, 71.1 % were aged over 65 years. The incidence of septic shock was 18.0 %, and 21.2 % required IMV. The early CRP dynamics (ΔCRP%) between day 1 and day 3 were significantly associated with both complications. An increase in CRP >16.8% from day 1 to day 3 predicted the development of septic shock (AUC = 0.90, sensitivity 78.3%, specificity 90.5%), whereas a decrease in CRP <41.1% from day 1 to day 3 predicted the requirement for invasive mechanical ventilation (AUC = 0.78, sensitivity 92.9%, specificity 54.0%). Conclusion: Early CRP dynamics (ΔCRP%) between day 1 and day 3 were identified as an independent prognostic marker for the development of septic shock and the requirement for invasive mechanical ventilation in hospitalized patients with community-acquired pneumonia. Among these outcomes, CRP kinetics demonstrated outstanding prognostic accuracy in predicting septic shock.

Article Details

References

1. GBD 2021 Causes of Death Collaborators, Global, regional, and national causes of death in 2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet, 2023. 401(10389): p. 1542–1605.
2. National Institute for Health and Care Excellence (NICE), Pneumonia: diagnosis and management (NG250). NICE Guideline, 2025.
3. Dinh, A., et al., Community-acquired pneumonia: 2025 French guidelines. Respir Med Res, 2025. 101161.
4. Saldías Peñafiel, F., et al., Utilidad de la proteína C reactiva sérica en el diagnóstico y tratamiento del adulto inmunocompetente hospitalizado por neumonía adquirida en la comunidad. Rev Med Chile, 2019. 147: p. 983–992.
5. Huang, S., et al., Relationships between human serum albumin levels and septic shock, in-hospital, and out-of-hospital mortality in elderly patients with pneumonia in different BMI ranges. Pneumonia, 2024. 16:17.
6. Sellarès-Nadal, J., et al., Community-acquired pneumonia in hospitalised patients: changes in aetiology, clinical presentation, and severity outcomes in a 10-year period. Ann Med, 2022. 54(1): p. 3052–3059.
7. Meslé, V., et al., Unexpected discovery of CRP analytical interference: A case report. Clin Biochem, 2024. 130: p. 110781.